The mechanisms that control herpes simplex virus type 1 latency and reactivation are still poorly understood. We developed an in vitro murine neuroblastoma cell HSV-infected, acyclovir suppressed model to study the influence of different cyclic nucleotide mediators on the latency and reactivation of HSV-l. A positive cDNA 'in situ' hybridisation for HSV genome was used to prove the establishment of a viral host cell nuclear relationship. An ABC-immunoperoxidase reaction to cell surface Latently infected trigeminal ganglia have been thought to be the source of virus for recurrent herpetic keratitis in humans, a major cause of corneal blindness in developed countries. 1 Current antiviral therapy has proved ineffective in preventing the estab lishment of latency. The molecular details of the relationship between virus and host cell DNA during the latent state have not been definitely elucidated. 2 • 3 An alternative thera peutic strategy to viral DNA elimination from latently infected ganglia might include efforts to indentify and manipulate factors involved in the control of mechanisms responsible for the induction of and reactivation from the latent state. A variety of physiological (fever, trauma, sunburn, menses, stress) and experi mental (epinephrine, prostaglandins, ultra-
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Results
A positive cDNA 'in situ' hybridisation for HSV was a consistent finding in all coverslips containing HSV-l infected neuroblastoma (Table I) . HSV-l infected neuroblastoma cells treated with NGF and ACV also showed, con sistently, cDNA positive cells for HSV DNA while, at the same time, manifesting no mature, late (gamma) HSV proteins. Super natants from these cultures consistently failed to yield infectious virions when cultured on Vero cells; supernatants from such cultures not treated with experimental mediators were HSV negative for 18 hours after removal of ACV from the culture medium (desuppression) .
The results show that the mean HSV reac tivation time from an acyclovir-induced 'latency' in neuroblastoma cells was 18 hours (positive ABC immunoperoxidase reaction) after the withdrawal of the ACV-7S-NGF solution (Fig. 2) . This finding was consistent throughout the different sets of experimentse Cultivation of supernates on vero cells pro. duced CPE due to mature HSV. This tra· ditional assay, however, was clearly less sensitive and less precise than was the ABC assay for HSV gamma proteins. The mean time to HSV reactivation following with drawal of ACV as determined by supernate HSV positivity was 24 hours (Table II) .
Of the cyclic nucleotide mediators that increase the intracellular levels of cAMP (Table II) , the phosphodiesterase inhibitor theophylline (50 f.A,g/ml) and dibutyril-cAMP (0. 1, 0. 5, 1 mg/ml) produced the most pro nounced acceleration of the reactivation time of HSV-l, six hours compared to the controls' mean reactivation time of 18 hours (p<0.05).
Epinephrine (10, 20 f.A,g/ml), an adrenergic agonist, accelerated the reactivation of HSV-l by eight hours (mean time to reactivation, 10 hours; control reactivation time, 18 hours) (p<0.05) (Fig. 3) .
Lower concentrations of theophylline (10, Significant values on the ABC immunoperoxidase staining using Analysis of Variance test (P<0.05). Verapamil at lower dose (10 !-tg/ml) and iso proterenol (2.5, 5, 10 !-tg/ml), a beta adrener gic agonist, had no demonstrable effect on the induction of HSV-l reactivation in this model.
Of the mediators that increase intracellular levels of cGMP by activation of the guanylate cyclase system (Table III) Insulin (0.1, 0.5, 1 Vlml) also prolonged the reactivation time of HSV-l by six hours compared to controls (p<0.05) (Fig. 5 ).
Carbamylcholine at a lower dose (5 !-tg/mJ) and dibutyril-cGMP (0. 1, 0.5, 1 mg/ml) showed no effect on prolonging the 'latency' of HSV-l in this neuroblastoma cell model. Cyclosporine at low doses (1, 2. 5, 5 [lg/ml) due to its high toxicity on neuroblastoma cells induced viral reactivation moderately com pared to controls (Table IV) .
Dexamethasone phosphate (20 [lg/ml) and sodium cromoglycate (25 [lg/ml) did not have an effect in inducing reactivation or prolong ing the latent state of HSV-l.
Discussion
Recurrences of ocular HSV are related to the well known cycle of latent trigeminal gan glionic infection, ganglionic viral reactiva tion. and ocular virus shedding. 4 -111 , 12 -t5 Despite the recent advances into the nature of HSV latency, little is known about the mech anisms of HSV-l latency and reactivation. Therefore there are no clinically reliable methods of preventing the establishment of latent infection of the trigeminal ganglion, of inhibiting ganglionic viral reactivation, or of preventing viral shedding. An alternative strategy for preventing the cumulative per manent structural alterations of the eye which compromise vision is to manipulate the physiologic changes which control HSV latency and reactivation. If latency is control led by the expression of certain genes not expressed during lytic infection, how can these genes be activated? If latency is control led by the lack of expression of certain genes, how can these genes be blocked? If reactiv ation is the suppression of the mechanisms maintained during latency, how can this sup pression be inhibited? It has been shown that regulation of cellular responsiveness to cAMP may be regulated at multiple biochemical levels that can clearly affect the macro molecular processes involved in gene expression, which in turn may lead to stimu lation of cellular differentiation l" or prolifer ation. 17 · tH Similarly in HSV-l infection, biochemical signals generated at the host plasma membrane by ligand receptor-coupled 'second messenger' (cAMP or cGMP) could foster the expression of specific genes funda mental in the initiation and maintenance of HSV-l latency or induction of reactivation. Recent studies on latency show that latency associated transcripts (LATs), although not essential for establishment or reactivation of viral latency, may play a role in the efficiency of reactivation in vitro. 19 It has been suggested that LATs expression may be inducible by extracellular signals through a pathway invol ving the cAMP dependent protein kinase. 2o We have previously shown that C-1300 (CCL147) neuroblastoma cells respond to dif ferent cyclic nucleotide mediators by altering the intracellular levels of cAMP and cGMP. 11 We have also shown in an in vivo/in vitro murine trigeminal ganglion latency model that first order messenger mediated modulation of ganglionic cyclic nucleotide concentrations is associated with perturba tions in the viral DNA-host DNA relation ship. Elevation in intracellular cGMP concentrations is associated with retardation of HSV reactivation from latency, and elevat ion of intracellular cAMP levels is associated with provocation of HSV reactivation. II We now report, in an effort to develop a more sensitive and accurate method for measuring the time for reactivation, the results of cDNA 'in situ' hybridisation and ABC immunope roxidase reaction during latency and reactiv ation in an in vitro murine neuroblastoma cell latency model. We find once again, in yet another latency model and using molecular 
